World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
75
Citations
18715
World Ranking
19178
National Ranking
644

Overview

Seetal Dodd is affiliated with Deakin University in Australia and has contributed extensively to the field of Medicine, particularly within Psychiatry and Mental Health.

Their research spans several specialized subfields including Psychiatry and Mental Health, Biological Psychiatry, Pharmacology, Clinical Psychology, and Experimental and Cognitive Psychology.

Key research topics addressed by Seetal Dodd encompass Bipolar Disorder and Treatment, Tryptophan and Brain Disorders, Treatment of Major Depression, Electroconvulsive Therapy Studies, COVID-19 and Mental Health, Stress Responses and Cortisol, and Mental Health Treatment and Access.

Seetal Dodd has published in various scientific venues with a particular concentration in:

  • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  • Neuroscience & Biobehavioral Reviews
  • CNS Spectrums
  • The International Journal of Neuropsychopharmacology
  • Clinical Psychopharmacology and Neuroscience

Frequent collaborators in research include Michael Berk, Olivia Dean, Vicki L. Ellingrod, Ann Arbor, and Jim Gums, indicating a network of partnerships within the psychiatric and pharmacological research communities.

Notable papers associated with Seetal Dodd include:

  • "Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation," 2021, American Journal of Psychiatry
  • "Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management," 2023, World Psychiatry
  • "The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment," 2021, Frontiers in Psychiatry
  • "Results of the COVID-19 mental health international for the general population (COMET-G) study," 2021, European Neuropsychopharmacology
  • "Effect of Aspirin vs Placebo on the Prevention of Depression in Older People," 2020, JAMA Psychiatry

Best Publications

  • Pathways underlying neuroprogression in bipolar disorder : focus on inflammation, oxidative stress and neurotrophic factors

    Michael Berk;Flavio P Kapczinski;Ana Cristina Andreazza;Ana Cristina Andreazza;Olivia Dean;Olivia Dean

  • Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

    Roger S McIntyre;Roger S McIntyre;Joshua D Rosenblat;Joshua D Rosenblat;Charles B Nemeroff;Gerard Sanacora

  • N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility

    Seetal Dodd;Olivia Dean;David Leon Copolov;Gin S Malhi

  • Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder

    M. Berk;M. Berk;S. Dodd;M. Kauer-Sant'Anna;G. S. Malhi

  • The validity of the 21-item version of the Depression Anxiety Stress Scales as a routine clinical outcome measure.

    Felicity Ng;Thomas Trauer;Seetal Dodd;Tom Callaly

  • A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis

    Justin Davis;Harris Eyre;Felice N Jacka;Seetal Dodd

  • C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.

    Fernandes Bs;Steiner J;Bernstein Hg;Dodd S;Dodd S

  • Post-Operative Cognitive Dysfunction: An exploration of the inflammatory hypothesis and novel therapies.

    David R Skvarc;Michael Berk;Michael Berk;Linda K Byrne;Olivia M Dean

  • Setting the Stage: From Prodrome to Treatment Resistance in Bipolar Disorder

    Michael Berk;Michael Berk;Philippe Conus;Nellie Lucas;Karen Hallam

  • The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use.

    Michael Berk;Felicity Ng;Seetal Dodd;Tom Callaly

  • Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force

    Benicio N Frey;Ana C Andreazza;Josselin Houenou;Stéphane Jamain

  • History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder

    M. Berk;S. Dodd;P. Callaly;L. Berk

  • Vitamin D deficiency may play a role in depression

    Michael Berk;Kerrie M. Sanders;Julie A. Pasco;Felice N. Jacka

  • Glutathione: a novel treatment target in psychiatry.

    Michael Berk;Michael Berk;Felicity Ng;Olivia Dean;Seetal Dodd

  • Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention.

    Michael Berk;Alan Brnabic;Seetal Dodd;Seetal Dodd;Katarina Kelin

  • C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis

    Brisa S Fernandes;Brisa S Fernandes;Johann Steiner;Marc L Molendijk;Seetal Dodd

  • The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial ☆

    Michael Berk;Olivia Dean;Olivia Dean;Olivia Dean;Sue M. Cotton;Clarissa S. Gama

  • Staging in bipolar disorder: from theoretical framework to clinical utility

    Michael Berk;Robert Post;Aswin Ratheesh;Emma Gliddon

  • Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia.

    George Anderson;Michael Berk;Michael Berk;Seetal Dodd;Karl Bechter

  • Stage managing bipolar disorder

    Michael Berk;Lesley Berk;Seetal Dodd;Seetal Dodd;Sue Cotton

Frequent Co-Authors

Michael Berk
Michael Berk Deakin University
Olivia M. Dean
Olivia M. Dean Deakin University
Gin S Malhi
Gin S Malhi University of Sydney
Felice N. Jacka
Felice N. Jacka Deakin University
Julie A. Pasco
Julie A. Pasco Deakin University
Paul B. Fitzgerald
Paul B. Fitzgerald Australian National University
Flávio Kapczinski
Flávio Kapczinski McMaster University
Michael Maes
Michael Maes University of Electronic Science and Technology of China
Eduard Vieta
Eduard Vieta University of Barcelona
Mark A. Kotowicz
Mark A. Kotowicz University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up multiple alternative pathways, especially through flexible online education options. Many students seeking entry into healthcare start with accessible nursing programs. For those considering a nursing degree, there are nursing schools with high acceptance rates, making it easier to begin your journey.

If cost is a concern, pursuing cheap rn to bsn programs can offer a practical and affordable route to advance your qualifications. These options allow working nurses to earn a bachelor's degree online without interrupting their careers.

Individuals wanting to switch careers to nursing, even without a prior nursing background, can look into direct entry nurse practitioner programs for non-nurses online. These streamlined graduate programs combine essential training and can speed up your entry into advanced practice roles.

For experienced nurses aiming for leadership or academic roles, phd nursing programs are available online at competitive rates, helping you reach the highest levels in nursing research and education.

Best Scientists Citing Seetal Dodd

Trending Scientists

Recently Published Articles